Testicular cancer: Perils of very late presentation

Lancet

Volumn 359, Issue 9318, 2002, Pages 1632-1633

  Steele, Jeremy P C ^a   Oliver, R Timothy D ^a  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN;

ADOLESCENT; ADULT; CANCER CHEMOTHERAPY; CANCER RISK; CANCER SIZE; CASE REPORT; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE COURSE; HUMAN; MALE; METASTASIS; NOTE; ORCHIECTOMY; PATIENT ATTITUDE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; TESTIS CARCINOMA; TREATMENT OUTCOME;

EID: 0037062140     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(02)08544-6     Document Type: Note

References (6)

1. Cis-diamminedichloroplatinum, vinblastine, and bleomycin combination chemotherapy in disseminated testicular cancer
2. International Germ Cell Consensus Classification: a prognostic factor-based staging system for metastatic germ cell cancers
3. Testis conservation studies in germ cell cancer justified by improved primary chemotherapy response and reduced delay, 1979-1994
4. Health needs of asylum seekers and refugees